Video

What Unique Challenges Does AllianceRx Walgreens Prime Face?

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses challenges associated with combining specialty pharmacy operations.

Wright: We are a new company that combines the specialty pharmacies from Prime Therapeutics and Walgreens Specialty Pharmacy. So, our challenges are around how do we bring these 2 strong models together and pick the best of each piece and utilize the best pieces of the platform.

Of course, any specialty pharmacy that were to launch has limited distribution networks to navigate, payer networks to navigate, as well as all of the adherence [challenges]—we are in a highly regulated environment—and to make sure we are actually driving value in that space.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com